Paper39474602
CD38 regulates chronic lymphocytic leukemia proliferation via CD45 phosphatase activity.
Imbery JF and 11 others. Mol Ther Oncol, 2024. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. CD38 regulates chronic lymphocytic leukemia proliferation via CD45 phosphatase activity. Papers, record 39474602. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39474602
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 AI148073 | NIAID NIH HHS | United States | R01AI148073 | PubMed |
Source NIH RePORTER
References57
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23933259 | Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells. | Cell Rep | 2013 | https://conductscience.org/library/papers/23933259 | PubMed |
| 2 | 30940652 | Targeting CD38 Enhances the Antileukemic Activity of Ibrutinib in Chronic Lymphocytic Leukemia. | Clin Cancer Res | 2019 | https://conductscience.org/library/papers/30940652 | PubMed |
| 3 | 24130782 | Characterization of a new chronic lymphocytic leukemia cell line for mechanistic in vitro and in vivo studies relevant to disease. | PLoS One | 2013 | https://conductscience.org/library/papers/24130782 | PubMed |
| 4 | 25828863 | Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 Inhibitors. | J Med Chem | 2015 | https://conductscience.org/library/papers/25828863 | PubMed |
| 5 | 26930456 | CD38+ CD58- is an independent adverse prognostic factor in paediatric Philadelphia chromosome negative B cell acute lymphoblastic leukaemia patients. | Leuk Res | 2016 | https://conductscience.org/library/papers/26930456 | PubMed |
| 6 | 29069762 | Cell lines generated from a chronic lymphocytic leukemia mouse model exhibit constitutive Btk and Akt signaling. | Oncotarget | 2017 | https://conductscience.org/library/papers/29069762 | PubMed |
| 7 | 35767951 | Tetraspanin CD53 controls T cell immunity through regulation of CD45RO stability, mobility, and function. | Cell Rep | 2022 | https://conductscience.org/library/papers/35767951 | PubMed |
| 8 | 35819358 | Human CD38 regulates B cell antigen receptor dynamic organization in normal and malignant B cells. | J Exp Med | 2022 | https://conductscience.org/library/papers/35819358 | PubMed |
| 9 | 14616995 | Role of the microenvironment in chronic lymphocytic leukaemia. | Br J Haematol | 2003 | https://conductscience.org/library/papers/14616995 | PubMed |
| 10 | 21187443 | Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors. | J Immunol | 2011 | https://conductscience.org/library/papers/21187443 | PubMed |
| 11 | 20220774 | CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells. | Leukemia | 2010 | https://conductscience.org/library/papers/20220774 | PubMed |
| 12 | 12511405 | Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations. | Blood | 2003 | https://conductscience.org/library/papers/12511405 | PubMed |
| 13 | 34380042 | Integration of T helper and BCR signals governs enhanced plasma cell differentiation of memory B cells by regulation of CD45 phosphatase activity. | Cell Rep | 2021 | https://conductscience.org/library/papers/34380042 | PubMed |
| 14 | 10477712 | Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. | Blood | 1999 | https://conductscience.org/library/papers/10477712 | PubMed |
| 15 | 25760767 | Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma. | MAbs | 2015 | https://conductscience.org/library/papers/25760767 | PubMed |
| 16 | 19635795 | Galectin-1 co-clusters CD43/CD45 on dendritic cells and induces cell activation and migration through Syk and protein kinase C signaling. | J Biol Chem | 2009 | https://conductscience.org/library/papers/19635795 | PubMed |
| 17 | 19290935 | CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells. | Immunol Rev | 2009 | https://conductscience.org/library/papers/19290935 | PubMed |
| 18 | 22135465 | Quantitative differences in CD45 expression unmask functions for CD45 in B-cell development, tolerance, and survival. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22135465 | PubMed |
| 19 | 11699197 | CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia. | Leuk Lymphoma | 2001 | https://conductscience.org/library/papers/11699197 | PubMed |
| 20 | 34327725 | CD38 expression is an important prognostic marker in diffuse large B-cell lymphoma. | Hematol Oncol | 2021 | https://conductscience.org/library/papers/34327725 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42033923 | Emerging chemical strategies for CD38 inhibition: restoring NAD+ metabolism and disease control. | Bioorg Med Chem | 2026 | https://conductscience.org/library/papers/42033923 |
Source PubMed
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD38 | 952 | PubTator's text mining | https://conductscience.org/library/genes/952 | NCBI Gene |
| LGALS1 | 3956 | PubTator's text mining | https://conductscience.org/library/genes/3956 | NCBI Gene |
| PTPRC | 5788 | PubTator's text mining | https://conductscience.org/library/genes/5788 | NCBI Gene |
| SPN | 6693 | PubTator's text mining | https://conductscience.org/library/genes/6693 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39474602
GET https://conductscience.org/api/papers/v1/39474602/references?page=2